Aurora Spine Stock Performance
| ASAPF Stock | USD 0.20 0.02 9.09% |
The firm shows a Beta (market volatility) of 1.14, which signifies a somewhat significant risk relative to the market. Aurora Spine returns are very sensitive to returns on the market. As the market goes up or down, Aurora Spine is expected to follow. At this point, Aurora Spine has a negative expected return of -0.54%. Please make sure to confirm Aurora Spine's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Aurora Spine performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Aurora Spine has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -720.6 K |
Aurora |
Aurora Spine Relative Risk vs. Return Landscape
If you would invest 29.00 in Aurora Spine on December 20, 2024 and sell it today you would lose (9.00) from holding Aurora Spine or give up 31.03% of portfolio value over 90 days. Aurora Spine is currently producing negative expected returns and takes up 4.3253% volatility of returns over 90 trading days. Put another way, 38% of traded otc stocks are less volatile than Aurora, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Aurora Spine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aurora Spine's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Aurora Spine, and traders can use it to determine the average amount a Aurora Spine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ASAPF |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.54 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aurora Spine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurora Spine by adding Aurora Spine to a well-diversified portfolio.
Aurora Spine Fundamentals Growth
Aurora OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Aurora Spine, and Aurora Spine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aurora OTC Stock performance.
| Return On Equity | -0.27 | |||
| Return On Asset | -0.0851 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 66.73 M | |||
| Price To Book | 4.22 X | |||
| Price To Sales | 1.70 X | |||
| Revenue | 10.54 M | |||
| EBITDA | (1.9 M) | |||
| Cash And Equivalents | 758.98 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.27 M | |||
| Debt To Equity | 0.58 % | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (2.13 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 10.56 M | |||
About Aurora Spine Performance
By analyzing Aurora Spine's fundamental ratios, stakeholders can gain valuable insights into Aurora Spine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aurora Spine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aurora Spine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada. Aurora Spine is traded on OTC Exchange in the United States.Things to note about Aurora Spine performance evaluation
Checking the ongoing alerts about Aurora Spine for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Aurora Spine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aurora Spine generated a negative expected return over the last 90 days | |
| Aurora Spine has some characteristics of a very speculative penny stock | |
| Aurora Spine has high historical volatility and very poor performance | |
| The company reported the revenue of 10.54 M. Net Loss for the year was (2.36 M) with profit before overhead, payroll, taxes, and interest of 4.83 M. | |
| Aurora Spine has accumulated about 758.98 K in cash with (2.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 18.0% of the company shares are held by company insiders |
- Analyzing Aurora Spine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aurora Spine's stock is overvalued or undervalued compared to its peers.
- Examining Aurora Spine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aurora Spine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aurora Spine's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Aurora Spine's otc stock. These opinions can provide insight into Aurora Spine's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aurora OTC Stock analysis
When running Aurora Spine's price analysis, check to measure Aurora Spine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurora Spine is operating at the current time. Most of Aurora Spine's value examination focuses on studying past and present price action to predict the probability of Aurora Spine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurora Spine's price. Additionally, you may evaluate how the addition of Aurora Spine to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |